Z. Ahmad

发表

Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial.

B. Adams-Huet, A. Garg, L. Szczepaniak, 2013, European journal of endocrinology.

Early onset mandibuloacral dysplasia due to compound heterozygous mutations in ZMPSTE24

E. Zackai, L. Medne, A. Garg, 2010, American journal of medical genetics. Part A.

A regional analysis of payer and provider views on cholesterol management: PCSK9 inhibitors as an illustrative alignment model

Deepak L. Bhatt, K. Caldwell, H. Bays, 2020, Journal of managed care & specialty pharmacy.

Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.

D. Ledbetter, J. Knowles, D. Rader, 2018, Journal of the American College of Cardiology.

So Far, PCSK9 Inhibitors Work for All Heterozygous FH Patients.

M. McNutt, Z. Ahmad, 2015, Circulation. Cardiovascular genetics.

Premature coronary heart disease and autosomal dominant hypercholesterolemia: Increased risk in women with LDLR mutations.

Jedrek Wosik, B. Adams-Huet, A. Garg, 2016, Journal of clinical lipidology.

Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the CASCADE FH Registry.

Emily C. O'Brien, J. Knowles, S. Gidding, 2020, The Journal of pediatrics.

Abstract 4757: The ALK-F1174L mutation accelerates MYCN-driven tumorigenesis in a murine transgenic neuroblastoma model

S. Rodig, L. Chesler, R. George, 2011 .

Effect of PCSK9 Inhibitors on Clinical Outcomes in Patients With Hypercholesterolemia: A Meta‐Analysis of 35 Randomized Controlled Trials

B. Rangan, Subhash Banerjee, E. Brilakis, 2017, Journal of the American Heart Association.

Cholic Acid for Hepatic Steatosis in Patients with Lipodystrophy: A Randomized, 1

Harry Hines Boulevard, A. Garg, L. Szczepaniak, 2013 .

Familial defective apolipoprotein B-100: A review.

A. Miserez, Z. Ahmad, Lars H Andersen, 2016, Journal of clinical lipidology.

US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2016, Journal of clinical lipidology.

Identification of the Underlying Androgen Receptor Defect in the Dallas Reifenstein Family

R. Kittler, M. Mcphaul, C. Xing, 2017, Journal of the Endocrine Society.

Evaluating severe hypercholesterolemia in an uninsured, vulnerable population receiving care at a community clinic

A. Khera, Z. Ahmad, C. Ahmed, 2022 .

Extreme hypercholesterolemia presenting with pseudohyponatremia - a case report and review of the literature.

A. Garg, Iram Hussain, Z. Ahmad, 2015, Journal of clinical lipidology.

Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2019, Atherosclerosis.

Lowering Cholesterol with PCSK 9 Inhibitors

Z. Ahmad, 2017 .

Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.

B. Adams-Huet, Z. Ahmad, H. Khine, 2016, American heart journal.

Statin intolerance.

Z. Ahmad, 2014, The American journal of cardiology.

Cirrhosis‐induced pseudoglucagonoma syndrome in a patient with Type 2 Diabetes: an autopsy study

A. Garg, F. Vuitch, Z. Ahmad, 2011, Clinical endocrinology.

Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia

Laney K. Jones, M. Rich, C. Ballantyne, 2021, Journal of the American Heart Association.

Exact Inference for Meta-Analysis of Rare Events and Its Application in Human Genetics

D. Heitjan, S. Scholar, Z. Ahmad, 2022 .

Very Severe Hypertriglyceridemia in a Large US County Health Care System: Associated Conditions and Management

B. Adams-Huet, Sandeep R. Das, A. Garg, 2019, Journal of the Endocrine Society.

Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2017, Atherosclerosis.

Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry

Emily C. O'Brien, J. Knowles, D. Rader, 2016, Circulation. Cardiovascular genetics.

Low Prevalence of Mutations in Known Loci for Autosomal Dominant Hypercholesterolemia in a Multiethnic Patient Cohort

B. Adams-Huet, A. Garg, Chiyuan Chen, 2012, Circulation. Cardiovascular genetics.

Heterozygous Null LDLR Mutation in a Familial Hypercholesterolemia Patient With an Atypical Presentation Because of Alcohol Abuse

A. Garg, Z. Ahmad, Kamaldeep Panach, 2017, Circulation. Cardiovascular genetics.

Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1.

Z. Ahmad, D. Wilson, 2014, Journal of clinical lipidology.

Genetics and Dyslipidemia

N. Patni, Z. Ahmad, D. Wilson, 2016 .

Homozygous null mutations in ZMPSTE24 in restrictive dermopathy: evidence of genetic heterogeneity

Z. Ahmad, A. Garg, A. Agarwal, 2012, Clinical genetics.

Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior.

A. Fojo, S. Hammes, K. Pacak, 2008, Endocrine-related cancer.

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association.

A. Chait, J. Horton, M. Miller, 2022, Arteriosclerosis, thrombosis, and vascular biology.

Novel Lipid-Lowering Agents

A. Garg, Z. Ahmad, 2015 .

Genotype-phenotype relationships in patients with type I hyperlipoproteinemia.

A. Garg, S. Blumenschein, Z. Ahmad, 2014, Journal of clinical lipidology.

Over-the-counter fish oil use in a county hospital: Medication use evaluation and efficacy analysis.

B. Adams-Huet, Denise L Yeung, E. Moss, 2015, Journal of clinical lipidology.

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry

J. Knowles, D. Rader, C. Ballantyne, 2023, Journal of the American Heart Association.

Low Prevalence of Mutations in Known Loci for Autosomal Dominant Hypercholesterolemia in a Multi-Ethnic Patient Cohort Running title :

B. Adams-Huet, A. Garg, Z. Ahmad, 2012 .

Statin-Associated Adverse Events

Z. Ahmad, H. Khine, W. Yuet, 2015 .

Abstract 12169: LDL-C Levels and Treatment Patterns Among Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry

Emily C. O'Brien, J. Knowles, D. Rader, 2015 .

Monogenic and polygenic causes of low and extremely low LDL-C levels in patients referred to specialty lipid clinics: Genetics of low LDL-C.

C. McNeal, Z. Ahmad, B. Jakubowski, 2021, Journal of clinical lipidology.

Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.

D. Ledbetter, J. Knowles, D. Rader, 2018, Journal of the American College of Cardiology.

Abstract 19888: Improved Longitudinal Low Density Lipoprotein Cholesterol Goal Achievement Among Familial Hypercholesterolemia Patients in the CASCADE FH Patient Registry

Emily C. O'Brien, J. Knowles, D. Rader, 2017 .

Diagnosing Familial Hypercholesterolemia (FH) in the United States: Results from the CASCADE FH Patient Registry*†

Emily C. O'Brien, J. Knowles, D. Rader, 2015 .

INITIAL RESULTS FROM THE CASCADE-FH REGISTRY: CASCADE SCREENING FOR AWARENESS AND DETECTION OF FAMILIAL HYPERCHOLESTEROLEMIA

Emily C. O'Brien, J. Knowles, D. Rader, 2015 .